Search

everythinglearnresearchcommunity

for

Search:↓

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

p63 controls Satb1 to help skin develop properly.

Plucked hair follicles can help diagnose scalp lupus.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Finding functions for unknown GPCRs is hard but key for making new drugs.

AI can help diagnose Follicular Lymphoma by accurately identifying specific cell types.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Researchers successfully isolated and identified key markers of stem cell-enriched human hair follicle bulge cells.

The document says that hookworms are treated with mebendazole and stress-related hair loss usually gets better in 6 months, while other hair loss types have specific treatments.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

The enzyme PA-PLA1α is important for proper hair follicle development.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.